In representing clients in transactional and corporate matters, Peter Schaeffer has experience in the full range of issues faced by public and private companies. His transactional practice focus is in the areas of private equity, venture capital and mergers and acquisitions. His practice also includes ongoing representation of publicly traded corporations and privately held companies, including advice in regard to disclosure and compliance under the Securities Act of 1933 and the Securities Exchange Act of 1934.
Mr. Schaeffer advises private equity and venture investors in their investments and regularly represents strategic operating companies in their acquisitions and dispositions. He also represents early stage companies on formation issues, equity and compensation matters, licensing and in their venture capital and other financings. Mr. Schaeffer has represented several companies in their initial public offerings as well as in secondary offerings, PIPES, joint ventures and in the establishment of credit facilities. He represents clients in critical contract issues such as manufacturing and supply agreements, license agreements and employment and consulting agreements.
Mr. Schaeffer was named the winner of the M&A category in New York for the 2014 Client Choice Awards – USA & Canada. The Client Choice Awards recognize those law firms and partners around the world that stand apart for the excellent client service they provide. The criteria include a readership survey of International Law Office (ILO) and Lexology in-house counsel subscribers, which includes all members of the Association of Corporate Counsel.
Recent Representational Matters
Ongoing representation of a $4 billion investment firm in its private equity, acquisitions and dispositions, and in strategic transactions for its portfolio companies. Seven 2015 transactions (six acquisitions, one sale).
Ongoing representation of venture capital fund in its investments and dispositions. Seven 2015 transactions.
Representation of luxury beauty product and spa service retailer in its March 2015 sale to Macy’s, Inc.
Representation of global electronics company in their M&A transactions, including in its May 2015, acquisition of a leading manufacturer of LED luminaires.
Representation of certain selling shareholders of premium pet food company in one of the largest 2015 IPOs in July. Ongoing representation of this company in acquisitions and strategic transactions.
Representation of major fashion designer in his employment agreement and in his transactions with the NYSE listed international company that is branded with his name.
Representation of Fortune 100 Financial Services Company in their disposition and investments interests in publicly traded companies.
Ongoing representation of a NASDAQ listed fuel-cell manufacturing company, in connection with their M&A transactions, private placements, public offerings and SEC compliance.
Other Notable Representational Matters
Represented human resources counseling company in its sale to Marsh & McLennan.
Represented the special committee of NASDAQ listed healthcare technology company in the sale of the company to a private equity buyer.
Represented CME and medical publishing business in its $350 million sale to a private equity buyer.
Represented fashion client in the disposition of his business to private equity investors and separate sale of real estate interests.
Represented education company in its IPO, M&A transactions, strategic alliances and PIPE financings.
Represented a technology healthcare company in its IPO, M&A transactions, several strategic alliances with major media companies, venture capital financings, and its sale through a merger with another publicly traded company.
Represented consumer product company in connection with its acquisition of the global consumer product division of a multinational corporation and the simultaneous venture investment in, and bank financing of, this client.
Represented leading book publishing company in its acquisition of a publishing imprint in a bankruptcy transaction involving multiple bidders.
Represented medical publishing company in its dispositions of each of its medical publishing and contract research organization businesses and in its related dissolution. Prior representation of this client in various venture financings, bank financings, debt restructurings and acquisitions and strategic transactions.
Ongoing advice with the firm’s pro bono efforts, especially in connection with coordinating corporate associates’ involvement with various micro-entrepreneur pro bono clients.
- New York
Presenter, “Crowdfunding through Funding Portals: What You Need to Know LIVE Webcast,” The Knowledge Group, LLC (March 19, 2014)